2025 AGENDA

Loading

Generative AI for Drug Discovery

Tuesday 10 June 2025
Impact Stage
HealthTech
  • Generative AI is unlocking new frontiers in drug discovery by decoding the intricate languages of chemistry and biology. How can these technologies accelerate the development of treatments? 
  • How can LLM methodologies uncover insights previously hidden in drug discovery? 
  • What are the cost and time-saving implications of using generative AI in this space? 
  • How is generative AI shaping the future of drug discovery, delivering faster more effective solutions, and improving patient outcome? 
Moderator
Alex Eavis, Chief Product & Technology Officer - Genomics
Speakers
Layla Hosseini-Gerami, Co-Founder & Chief Data Science Officer - Ignota Labs
Danielle Belgrave, VP of AI/ML - GSK
Oliver Vince, Co-Founder - Basecamp Research
Boris Bogdan, Director, Healthcare and Life Sciences - AWS
Registration